DE69030616D1 - Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion - Google Patents

Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion

Info

Publication number
DE69030616D1
DE69030616D1 DE69030616T DE69030616T DE69030616D1 DE 69030616 D1 DE69030616 D1 DE 69030616D1 DE 69030616 T DE69030616 T DE 69030616T DE 69030616 T DE69030616 T DE 69030616T DE 69030616 D1 DE69030616 D1 DE 69030616D1
Authority
DE
Germany
Prior art keywords
chem
hydrogen
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69030616T
Other languages
English (en)
Other versions
DE69030616T2 (de
Inventor
Jun Inoue
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69030616D1 publication Critical patent/DE69030616D1/de
Application granted granted Critical
Publication of DE69030616T2 publication Critical patent/DE69030616T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Quinoline Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE69030616T 1989-11-20 1990-11-19 Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion Expired - Fee Related DE69030616T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP1301413A JPH03161441A (ja) 1989-11-20 1989-11-20 メイラード反応阻害剤

Publications (2)

Publication Number Publication Date
DE69030616D1 true DE69030616D1 (de) 1997-06-05
DE69030616T2 DE69030616T2 (de) 1997-12-11

Family

ID=17896581

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69030616T Expired - Fee Related DE69030616T2 (de) 1989-11-20 1990-11-19 Pharmazeutische Zusammensetzungen zur Hemmung der Maillardreaktion

Country Status (7)

Country Link
EP (1) EP0433679B1 (de)
JP (1) JPH03161441A (de)
KR (1) KR910009665A (de)
AT (1) ATE152352T1 (de)
CA (1) CA2029421A1 (de)
DE (1) DE69030616T2 (de)
ES (1) ES2100861T3 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2288732B (en) * 1994-04-13 1998-04-29 Quadrant Holdings Cambridge Pharmaceutical compositions
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
JP3988838B2 (ja) * 1996-05-29 2007-10-10 日本製粉株式会社 化粧料
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
CA2664159C (en) 1998-08-24 2013-06-04 Toshio Miyata Carbonyl-stress improving agent and peritoneal dialysate
FR2797443B1 (fr) * 1999-08-13 2003-10-31 Lafon Labor Procede de prepartion de quinoleine-5,8-diones
WO2001085136A2 (en) 2000-05-10 2001-11-15 Alliance Pharmaceutical Corporation Phospholipid-based powders for drug delivery
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
EP1458360B1 (de) 2001-12-19 2011-05-11 Novartis AG Pulmonale verabreichung von aminoglykosiden
US8409587B2 (en) 2002-11-01 2013-04-02 Glaxosmithkline Biologicals S.A. Immunogenic composition
FR2864535B1 (fr) * 2003-12-24 2006-12-22 Merck Sante Sas Derives acides de quinoline et leurs applications en therapeutique
JP4739705B2 (ja) * 2004-07-21 2011-08-03 ロート製薬株式会社 内服用組成物
JP4894902B2 (ja) * 2009-09-25 2012-03-14 パナソニック電工株式会社 除毛機
JP4971403B2 (ja) * 2009-09-25 2012-07-11 パナソニック株式会社 除毛機
CN108558906A (zh) * 2018-05-21 2018-09-21 日照市普达医药科技有限公司 一种治疗白内障药物苯并吩噁嗪类化合物及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4359455A (en) * 1979-10-30 1982-11-16 Sunstar Hamigaki Kabushiki Kaisha Diagnostic test composition for dental caries activity
IN164557B (de) * 1986-08-27 1989-04-08 Hoechst Ag
JPH01211595A (ja) * 1988-02-18 1989-08-24 Kikkoman Corp 新規Ｎ−アセチル−β−Ｄ−グルコサミン誘導体、その製法及びＮ−アセチル−β−Ｄ−グルコサミニダーゼ活性測定用試薬への利用
US5112739A (en) * 1988-08-02 1992-05-12 Polaroid Corporation Enzyme controlled release system

Also Published As

Publication number Publication date
EP0433679A2 (de) 1991-06-26
EP0433679A3 (en) 1992-03-04
JPH03161441A (ja) 1991-07-11
CA2029421A1 (en) 1991-05-21
EP0433679B1 (de) 1997-05-02
ES2100861T3 (es) 1997-07-01
KR910009665A (ko) 1991-06-28
DE69030616T2 (de) 1997-12-11
ATE152352T1 (de) 1997-05-15

Similar Documents

Publication Publication Date Title
ATE152352T1 (de) Pharmazeutische zusammensetzungen zur hemmung der maillardreaktion
DK0430045T3 (da) Ascorbinsyretocopherylphosphatdiestere til hæmning af Maillards reaktion
IE861820L (en) 2-hydroxy-2-phenylethylaminotetralines
HUT47217A (en) Process for producing pharmaceutical compositions containing indol derivatives as active components
IE890500L (en) 3-alkenyl-1-azabicyclo£3.2.0|hept-2-ene-2-carboxylic acid compounds
GR3018387T3 (en) Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them.
ATE157980T1 (de) Tetrahydropyrrolo(1,2-a>pyrazin-4-spiro-3'- pyrrolidin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
AU2246292A (en) Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use
UA42733C2 (uk) Похідні біснафталіміду та їх фармацевтично прийнятні кислотно-адитивні солі, фармацевтична композиція з цитотоксичною активністю, яка їх містить
ATE71092T1 (de) Hydroxybutenolid-derivate, ihre herstellung und ihre verwendung.
AU3595689A (en) Anthracycline derivatives having cytostatic activity
GB8608893D0 (en) D-nor-7-ergoline derivatives
EP0541726A4 (en) Growth factor compositions, preparation and use
AU2013888A (en) Uricosuric composition
TW353071B (en) Chromene compounds with neutroleptic activity, their preparation and pharmaceutical compositions
ATE97902T1 (de) Cephemverbindungen und verfahren zu ihrer herstellung.
TH13247EX (th) อนุพันธ์เททราไฮโดรฟิร์โรโล [1,2-a]ไพราชีน-4-สไพโร-3'-พิริโรลิดีน กรรมวิธีสำหรับเตรียมสารนั้นและสารผสมในทางเภสัชกรรมซึ่งมีสารนั้น

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee